DrugPatentWatch Database Preview
VELTASSA Drug Profile
When do Veltassa patents expire, and when can generic versions of Veltassa launch?
Veltassa is a drug marketed by Relypsa Inc and is included in one NDA. There are eleven patents protecting this drug.
This drug has one hundred and sixty-one patent family members in twenty-four countries.
The generic ingredient in VELTASSA is patiromer sorbitex calcium. One supplier is listed for this compound. Additional details are available on the patiromer sorbitex calcium profile page.
Summary for VELTASSA
| International Patents: | 161 |
| US Patents: | 11 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 11 |
| Drug Prices: | Drug price information for VELTASSA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VELTASSA |
| DailyMed Link: | VELTASSA at DailyMed |
Generic Entry Opportunity Date for VELTASSA
Generic Entry Date for VELTASSA*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
POWDER;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for VELTASSA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vifor Pharma | Phase 3 |
| New York University School of Medicine | N/A |
| University Hospitals Cleveland Medical Center | Phase 4 |
Pharmacology for VELTASSA
| Drug Class | Potassium Binder |
| Mechanism of Action | Potassium Ion Binding Activity |
Synonyms for VELTASSA
| 1415477-49-4 |
| Calcium, hydrolyzed divinylbenzene-Me 2-fluoro-2-propenoate-1,7-octadiene polymer sorbitol complexes |
| Cross-linked polymer of calcium 2-fluoroprop-2-enoate with diethenylbenzene and octa-1,7-diene, combination with D-glucitol |
| Patiromer sorbitex calcium |
| Patiromer sorbitex calcium [USAN] |
| RLY5016S |
US Patents and Regulatory Information for VELTASSA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Relypsa Inc | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Relypsa Inc | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Relypsa Inc | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Relypsa Inc | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VELTASSA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2007531758 | Start Trial |
| European Patent Office | 1732524 | Start Trial |
| United Kingdom | 0906966 | Start Trial |
| Australia | 2012254879 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for VELTASSA
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2957286 | LUC00094 | Luxembourg | Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
| 2365988 | PA2018004 | Lithuania | Start Trial | PRODUCT NAME: PATIROMERO, SORBITOLIO IR KALCIO KOMPLEKSAS IR JO DRUSKOS; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
| 2269589 | CA 2018 00003 | Denmark | Start Trial | PRODUCT NAME: PATIROMER AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179 20170721 |
| 1732523 | 2018C/004 | Belgium | Start Trial | PRODUCT NAME: PATIROMER OF EENDER WELK ZOUT OF AFGELEIDE ERVAN; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
